winners and losers

drag2share: Tracking Winners And Losers In The Multibillion-Dollar Mobile Phone Payments Revolution

source: http://feedproxy.google.com/~r/businessinsider/~3/-XKigzrRzkc/mobile-phone-payments-solutions-2013-8

bii_mobilepayments2013_paypalConsumers gravitate to convenience. That’s as true with payment technologies as it is with anything else. A prime example is the decades-old trend away from cash or checks and toward credit cards.

Now, the mass adoption of smartphones and tablets has set the stage for a new move — away from offline card-and cash-based transactions and toward those completed on mobile. The old dream of the “digital wallet” is coming true in a very particular mobile-led fashion.


drag2share – drag and drop RSS news items on your email contacts to share (click SEE DEMO)

Tags: , , , , , , , , , , , , ,

Friday, August 16th, 2013 news No Comments

Everyone Is Talking About The Publicis-Omnicom Merger [THE BRIEF]

Source: http://www.businessinsider.com/everyone-is-talking-about-the-publicis-and-omnicom-merger-the-brief-2013-7

hand shake

Good morning, AdLand. Here’s what you need to know today:

Of course the biggest news from this weekend is that formerly number two and three holding companies, Publicis and Omnicom, merged. Revenues for Publicis Omnicom Groupe will now far exceed WPP at $23 billion.

GroupM Global President Dominic Proctor condescends the merger. Although he said that it is “an interesting move,” Proctor continued, “neither Omnicom nor Publicis was able to bring their investment teams together effectively as individual companies, so it be fun to see if they can now do it together.” GroupM is part of WPP.

Havas CEO David Jones said that the merger will be bad for clients and employees.

FT takes a look at Omnicom’s John Wren, “the quiet man of ad land.”

And Digiday’s Brian Morrissey takes a peek at the winners and losers of the merger.

Speaking of Digiday, the site had a makeover.

Ketchum hired Andrew Ager, formerly at Weber Shandwick, as a creative director in its London office.

Ad agency Crush attached a GoPro camera to an adorable dog. Adweek has the pictures.

Stephen Colbert has some thoughts on branding.

 

Tags: , , , , , , , , , , , , , , , , ,

Monday, July 29th, 2013 news No Comments

What’s Taking So Long, And Who’s Going To Win?

Source: http://www.businessinsider.com/mobile-payments-whats-taking-so-long-and-whos-going-to-win-2012-6

Square Estimated Daily Payment Volume And Revenues

Mobile payments: everyone talks about it, but no one knows exactly how it works or who will win

In our special report, Business Insider Intelligence lays out the four kinds of mobile payment solutions that currently matter:

  • Carrier billing. Where the consumer pays by text message and the charge is added to their phone bill. This is great for a variety of specific use cases (reaching the unbanked, especially teenagers; ecommerce and gaming), but is crimped by carrier fees and control.
  • Near-Field Communications (NFC). Where the consumer can pay at the point of sale by waving his phone in front of a terminal. NFC has been overhyped: it’s not more convenient than cash or credit, and the many companies who want a piece of NFC are canceling each other’s efforts out.
  • Apps. Where the consumer uses an app on his smartphone to pay, typically by scanning a barcode at the register. We believe this is especially useful for specific companies and retailers to offer, as it allows them to offer loyalty rewards and discounts on top of payments.
  • Card readers. Pioneered by startup Square, with recent entries from eBay (PayPal), Intuit, and Verifone, these solutions allow merchants to take payments by plugging a card reader into a smartphone or tablet. They’re very convenient (swiping a credit card is already ingrained consumer behavior) and piggyback on the existing credit card network. Card reader companies can offer value-added services on top of the payments experience to spur adoption by merchants and consumers.

We also:

For full access to the report, sign up for a free trial subscription today.

Please follow SAI on Twitter and Facebook.

Join the conversation about this story »

Tags: , , , , , , , , , , , , , , , , , , ,

Wednesday, June 27th, 2012 news No Comments

Here Are The Winners And Losers

Source: http://www.businessinsider.com/super-bowl-ads-2012-here-are-the-winners-and-losers-2012-2


clint eastwood

There’s fascinating disconnect between which advertisers the media thinks did well on last night’s Super Bowl and what the research says was effective.

To hear the business press tell it, Clint Eastwood’s “Halftime in America” spot rocked the house. It was indeed a great spot from a creative point of view.

But it didn’t even show up in the Ace Metrix Top 10. Ace Metrix measures a panel of 500 consumers who watch ads and rate them for effectiveness. That research says Doritos’ sling baby ad won the night.

It was also a big night for dogs. Volkswagen’s much anticipated follow-up to its little Darth Vader spot from last year used an obese dog getting in shape to gets its revenge on a VW it wanted to chase down the street (and then somehow ended up in the Star Wars cantina scene).

Skechers used a dog — Mr. Quiggly — in a greyhound race.

As did Bud Light, whose appeal with Weego, a rescue dog, was heartwarming.

So did Doritos, in another comedic appeal revolving around the whole Dogs v. Cats war.

There weren’t any total disasters — last year both Groupon and HomeAway had to apologize for their ads — but there were some failures in the sense that clients ads bored people or went unnoticed.

Chase ran an ad that for the life of me I can’t recall even though I am paid to remember these things. And TaxACT’s ad, featuring a kid who urinates in a swmming pool, was disgusting.

Later today — much later — we’ll take a look at how B.I.’s readers judged the ads with the results of our Super Bowl ad readers’ poll. Vote early, and often!

Please follow Advertising on Twitter and Facebook.

Join the conversation about this story »

See Also:



Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Monday, February 6th, 2012 news No Comments

The World’s Largest Blockbuster Drug Just Went Generic — Here Are The Winners And Losers (PFE, WPI, ABC, TEVA, MRK, MYL, CVS, WAG)

Source: http://www.businessinsider.com/the-nations-largest-blockbuster-drug-just-went-generic-2011-11


pfizerap1017

With the expiration of Pfizer’s patent exclusivity on Lipitor, the nation’s top selling drug will go generic and see a market share split that will force manufacturers into a share race.

Lipitor, a cholesterol drug that reduces cholesterol, came to market in 1997 and ultimately peaked with sales of $13 billion. Last year, it contributed $10.7 billion in revenue to Pfizer.

Analysts remain divided over how much market share Pfizer will be able to hold on to. The company is aggressively discounting the drug through a program to entice patients to remain on Lipitor. Over the coming 180 days, Watson Pharmaceuticals and Ranbaxy Laboratories of India will enter the market.

Eight Citi analysts poured over data and see Pfizer retaining 40-50% of market share over the next half year. Delays out of Ranbaxy, which were prompted by U.S. regulatory bans over questionable quality concerns, will aid Pfizer.

But after the 180 days, when another round of pharmaceuticals like Teva and Aurobindo are allowed entry, the cost of Lipitor will drop to “pennies a day,” Citi analyst John Boris writes.

However, most of Lipitor’s decline has already been priced into Pfizer stock over the past year. “We maintain our Pfizer 4Q11E/2012E Lipitor sales/EPS contribution at $930M/$640M,” Boris continues. That represents a Lipitor sales contribution of 14-18% of fourth EPS, before falling to just 2% of earnings in 2012.

The largest to benefit from the change may be drug stores like CVS and Walgreens, which may see an uptick as more patients can afford to take cholesterol medications, even as average drug prices decline.

“In addition, we believe that the drugstores will be able to generate stronger gross profit dollars as the average gross margin for generic drugs is generally 50 to 60%, while the average gross margin for branded drugs is approximately 20%,” Boris says. 

Meanwhile, Pfizer is betting its name on smaller blockbusters in other drug categories to contribute $4 billion in new revenue by 2014 as it re-emerges in a world post-Lipitor.

Please follow Money Game on Twitter and Facebook.

Join the conversation about this story »

See Also:




drag2share – drag and drop RSS news items on your email contacts to share (click SEE DEMO)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Wednesday, November 30th, 2011 news No Comments

Dr. Augustine Fou is Digital Consigliere to marketing executives, advising them on digital strategy and Unified Marketing(tm). Dr Fou has over 17 years of in-the-trenches, hands-on experience, which enables him to provide objective, in-depth assessments of their current marketing programs and recommendations for improving business impact and ROI using digital insights.

Augustine Fou portrait
http://twitter.com/acfou
Send Tips: tips@go-digital.net
Digital Strategy Consulting
Dr. Augustine Fou LinkedIn Bio
Digital Marketing Slideshares
The Grand Unified Theory of Marketing